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Abstract 
BACKGROUND: Intra-peritoneal adhesions (IPAs) common occurre in post abdominal surgical. Athough many 
methods have been developed for controlling IPAs, including mesenchymal stem cells (MSCs) application, 
however, there is none completely preventing in due to the mesothelial structure may promote the prolonged 
inflammations leading. Nevertheless hypoxia-MSCs (H-MSCs) have more potent in controlling the inflammation 
than normoxia-MSCs (N-MSCs) by releasing several anti-inflamation particularly IL-10, however the H-MSCs 
application to inhibit IPAs remain unclear.  
AIM: The aim of this study was to investigate the effectiveness of H-MSCs in preventing the AIPs event by 
releasing IL-10 on the ileum abrasion sutured omental patch as the animal model of peritoneal adhesion. 
METHODS: Using 24 IPAs animal model were randomly divided into 4 groups: Sham (Sh), Control (C), H-MSCs 
at high dose (T1) and H-MSCs at low dose (T2). H-MSCs were incubated under hypoxic conditions (5% O2), 37°C 
and 5% CO2 for 24 hours. The expression level of IL-10 was performed using RT-PCR analysis. The macroscopic 
appearance of IPAs was evaluated using Nair’s scale base on the absence/presence of adhesion, whereas the 
microscopic by Zuhlke’s scale at Hematoxylin and eosin (H&E) staining. 
RESULTS: This study showed a significanly increase in IL-10 expression (p < 0.05) at all T groups. In line with 
this, we also found a significant difference in IPAs between T groups and Control as well as a Sham (p < 0.05) 
either in the macroscopic or microscopic analysis. 
CONCLUSION: H-MSCs has a robust ability in inhibiting severe IPAs characterized by the decreased of adhesion 
formation and the enhanced expression of IL-10. 
 
 
 
Introduction 
 
Intra-peritoneal adhesions (IPAs) are the most 
common scar tissue occurring in post abdominal 
surgical, in addition to as a consequence of prolonged 
intra-abdominal inflammation [1], [2]. The incidence of 
post-surgical IPAs is from 67 to 97%, whereas their 
complications, such as the small-bowel obstructions, 
chronic abdominal, pelvic pain and female infertility 
may induce severe health problems [3]. Several 
methods have been developed for controlling IPAs, 
such as laparoscopy and surgical barriers [4], [5], 
however, there is none completely preventing in 
adhesion development. Dysregulation of the serious 
healing process of mesothelial structural are the basis 
of peritoneal adhesion formations due to the unique 
characteristic of mesothelial that have immune-like 
capacity. The post-injury mesothelial denudation may 
promote the prolonged inflammations leading to the 
impairment of fibrinolytic regulation and the extension 
of extracellular matrix (ECM) deposition [5]. 
Mesenchymal stem cells (MSCs) play a key 
role in completely accelerating wound healing by 
responding injury signals and migrating toward the 
injury site to control the inflammation process. These 
immunoregulatory properties of MSCs are due to their 
ability to suppress the inflammatory milieu by 
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releasing several anti-inflammatory cytokines such as 
IL-10, IDO, PGE2, TGF-b, HGF and nitric oxide [6]. 
Several studies of MSCs have been performed to 
prevent IPAs, such as decreasing the inflammatory 
response and fibrin formation as well as increasing 
fibrin lysis [7], [8]. However, intraperitoneal MSCs are 
yet ineffective in preventing IPAs although they can 
control the inflammatory process [9]. Another study 
also reported that the topical MSCs are not effective 
to prevent the IPAs event. The reason behind the 
absence of MSCs into injured peritoneum is the 
incompetence of MSCs to counter phagocytosis of 
monocyte-macrophage system [10]. On the other 
side, the recent study revealed that hypoxia-MSCs (H-
MSCs) have superior effect to accelerate wound 
healing than normoxia-MSC (N-MSCs) [11], [12]. 
Theoretically, MSCs may express a number 
of markers, including CD105, CD73, CD90, CD166, 
CD44 and CD29 dan lack of the expression of CD45, 
CD34, CD14 or CD11b, CD79a or CD19, and HLA 
class II. In addition to multilineage differentiation 
capacity, MSCs also have immune regulatory 
properties by secreting anti-inflammatory cytokines 
[13], [14]. MSCs under hypoxia condition can mimic 
the physiological niche including in their in-vivo 
environment that potentially offer the benefit of clinical 
case. H-MSCs are more potent in controlling 
inflammation than N-MSCs by increasing more anti-
inflammatory cytokine [15]. Specifically, IL-10 as a 
pleiotropic anti-inflammatory cytokine released by 
MSCs can inhibit macrophage activation, T cell and 
NK cell proliferation. On the other side, MSCs can 
control pro-inflammatory cytokines release, 
particularly IFN-g, IL-2, TNF-a. The release of IL 10 
and TGF-b of MSCs post-TNF-α exposure may 
suppress inflammation, thus accelerate the wound 
healing process [16]. 
The previous study reported that the majority 
of MSCs do not survive in the hypoxia milieu that 
frequently occurred in most injured tissue, including in 
IPAs [19]. Therefore, a pre-conditioning period of 
MSCs under hypoxia for supporting their adaptation 
prior to their exogenous administration is needed. In 
this study, we aimed to investigate the effectiveness 
of H-MSCs in preventing the IPAs event by releasing 
IL-10 on the ileum abrasion sutured omental patch as 
the animal model of peritoneal adhesion. 
 
 
Methods 
 
IPAs Animal model 
The study was approved by the experimental 
animal's ethics committee of the medical faculty of 
Sultan Agung Islamic University, Semarang, 
Indonesia. A total of 24 healthy 8-weeks-old male 
Wistar-albino rats weighing between 250 and 300 g 
which purchased from the animal holding unit, Faculty 
of Veterinary Medicine, Gadjah Mada University were 
used. Rats were acclimatized and housed in 12 h 
light-dark cycle standard cages at 24°C with food and 
water ad-libitum. After fasting for 12 h, rats were 
anesthetized by intraperitoneal administration of 
ketamine and xylazine (90 and 10 mg per kg body 
weight; respectively). The surgical procedure was 
performed according to described previously [37]. The 
operations were performed under aseptic conditions 
and took less than 20 minutes for each rat to minimize 
room air tissue dying effect. Musculoperitoneal layer 
was incised and opened over a length of 3 cm at the 
linea alba after skin ventral midline incision. In order to 
induce IPAs, the standardized surgical injuries were 
applied to one side of the terminal ileum (3 cm from 
cecum) with 0.5 × 0.5 cm size on the right sidewall of 
ileum by brushing with a cytobrush (Gynobrush, 
Langenbrink, Emmendingen, Germany) until the 
punctuate red spot was observable as visual indicator 
for ileum trauma. Following the intervention, the 
abdominal incision was closed with 4 – 0 polygelatin 
suture and rats were reared in battery cages for 14 
days. 
 
MSCs isolation and culture 
MSCs were isolated from the umbilical cord 
(UC) obtained from pregnant single Wistar-albino rats 
and expanded as described previously [28]. Briefly, 
UCs were chopped into smaller pieces and 
transferred into a T25 culture flask (Corning, 
Tewksbury, MA, USA) containing DMEM (Gibco™ 
Invitrogen, NY, USA) which supplemented with 10% 
FBS (Gibco™ Invitrogen, NY, USA), 1% penicillin 
(100 U/mL) and 0,25% streptomycin (100 µg/mL) 
(Gibco™ Invitrogen, NY, USA) and incubated at 37°C, 
5% CO2 and ≥ 95% humidity. The medium was 
replaced every 3 days and harvested after reaching 
80% confluenct (14 days). The 4-6
th
 passaged MSCs-
like were employed for the experiments. 
 
H-MSCs osteogenic differentiation assay 
The H-MSCs were cultured in 24 well plate 
(1.5 x 104 cells/well density) with standard medium 
containing DMEM (Sigma-Aldrich, Louis St, MO), 
supplemented with 10% FBS (Gibco™ Invitrogen, NY, 
USA), 1% penicillin (100 U/mL) and 0,25% 
streptomycin (100 µg/mL) (Gibco™ Invitrogen, NY, 
USA) at 37°C, 5% CO2, and ≥ 95% humidity. After 
reaching 95% confluent, standard medium were 
aspirated and replaced with osteogenic differentiation 
medium containing Human MesenCult™ Osteogenic 
Differentiation Basal Medium (Stem Cell 
Technologies, Singapore), augmented with 20% 
Human MesenCult™ Osteogenic Differentiation 5X 
Supplement (Stem Cell Technologies, Singapore) and 
1% L-Glutamine (Gibco™ Invitrogen, NY, USA). The 
differentiation medium was renewed every 3 days. 
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The bone matrix was formed after 15 days and can be 
visualized by 2% Alizarin red solution staining. 
 
H-MSCs characterization 
H-MSCs surface markers at the 4-6
th
 passage 
were analyzed by flow cytometry analysis according to 
company protocols. Briefly, the cells were 
subsequently incubated in the dark room with 
allophycocyanin (APC) mouse anti-human CD73, 
fluorescein sothiocyanate (FITC) mouse anti-human 
CD90, perCP-Cy5.5.1 mouse anti-human CD105, and 
phycoerythrin (PE) mouse anti-human Lin negative 
(CD45/CD34/CD11b/CD19/HLA-DR) antibodies. H-
MSCs cells were stained with MSC specific antibody 
for 30 minutes at 4°C, then examined and analyzed 
with a BD Accuri C6 Plus flow cytometer (BD 
Biosciences, San Jose, CA, USA). 
 
H-MSCs induction and administration 
For inducing H-MSCs, MSCs derived from the 
4
th
 passage were incubated under 5% O2 condition in 
a hypoxia incubation chamber (STEMCELL 
Technologies, Biopolis, Singapore) for 24 h at 37°C 
and 5% CO2, then collected for the following 
experiment. The IPAs animal model was treated by 3 
x 10
6
 as a high dose (T1) and 1,5 x 10
6
 as a low dose 
of H-MSCs (T2) via submucosal injection, whereas 
the Sham group received NaCl only and Control group 
received the omental patch treatment. 
 
Macroscopic evaluation of IPAs 
Fourteen days after abdominal surgery, a 
necropsy was performed by opening the abdominal 
cavity through a reverse U-shape incision. The 
absence/presence of IPAs was evaluated by Nair’s 
scale [9] (Table 1). 
Table 1: Nair’s macroscopic adhesion grade 
Grade 0 No adhesions 
Grade 1 One adhesion band only between the organs or one organ to the abdominal wall 
Grade 2 Two adhesion bands between the organs or one organ to the abdominal wall 
Grade 3 More than 2 adhesion bands between the organs or one organ to the abdominal 
wall. 
Grade 4 Adhesion of all viscera to the abdominal wall 
 
Microscopic analysis 
The terminal ileum sample was totally excised 
and removed from the abdomen. A single-blinded 
pathologist assessed the excised tissues, fixed them 
in 10% buffer formalin, embedded with paraffin, and 
then sectioned. Finally, the slide was stained by 
hematoxylin and eosin (H & E), whereas the 
histopathology appearance was evaluated using the 
Zühlke’s scale at high magnification [9] (Table 2).  
 
 
Table 2: Zühlke’s microscopic adhesion grade  
Grade 1 Weak connective tissue, rich cell, new and old fibrin, thin reticulin fibriles 
Grade 2 Connective tissue which has cells and capillaries and few collagen fibers 
Grade 3 Thicker connective tissue. Few cells and elastic and smooth muscle fibers, more 
vessels 
Grade 4  
Old and thick granulation tissue, poor cells, difficult separation of serosal 
surfaces 
 
IL-10 relative expression analysis 
The RNA isolation on 100 mg of tissue 
sample at 14 was performed using the TRI Reagent 
according to the manufacturer’s instructions (Sigma-
Aldrich, Dorset, UK). Reverse transcription of 1 µg of 
total RNA was performed using Enhanced Avian First 
Strand cDNA Synthesis Kit according to the 
instructions given (Sigma-Aldrich, Dorset, UK) and 
step-down PCR was performed using Eco Real-Time 
PCR System (Illumina Inc., San Diego CA, USA). An 
oligo d(T) primer was used for RT and 20 µL of 
reaction mix was incubated for 10 minutes at 70°C 
and 15 minutes at 45°C. The 2-step quantitative real-
time PCR was performed using an Eco Real-Time 
PCR System.  
Expression level analysis of beta-actin 
(housekeeping gene) and IL-10 were carried out using 
KAPA SYBR® FAST Universal Kit (Sigma-Aldrich, 
Dorset, UK) in combination with oligonucleotide primer 
(IL-10 forward 5’-GCAGGACTTTAAGGGTTACTTGG-
3’ and reverse 5’-CCTTTGTCTTGGAGCTTATTAAA-
3’; beta-actin forward 5'-
ATTGGCAATGAGCGGTTCCGC-3' and reverse 5'-
CTCCTGCTTGCTGATCCACATC-3').  
For qPCR analysis, 10 µL of KAPA SYBR® 
FAST qPCR master mix, forward and reverse primers 
(200 nM) and 3 ng of cDNA template was added and 
incubated in thermocycling conditions (95°C for 3 min, 
followed by 45 cycles of 95°C for 10 sec and 60°C for 
30 sec). Expression levels were calculated by ΔΔCt 
method (2−ΔΔCt formula) using Eco Study Software 
(Illumina Inc., San Diego CA, USA), after being 
normalized to the Cq-value of the beta-actin 
housekeeping gene. 
 
Statistical analysis  
All statistical tests were performed using the 
SPPS v. 20 (SPPS Inc, Chicago, IL USA). The data 
descriptives were presented in means ± standard 
errors. Both macroscopic and microscopic IPAs 
classification grades were presented in numbers. For 
analyzing all parameters, a one-way analysis of 
variance (ANOVA) was performed and followed by a 
Tukey’s multiple comparisons post-hoc test. A P-
value, less than 0.05 was considered as statistically 
significant. 
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Results 
 
H-MSCs characterisation and 
 differentiation 
The H-MSCs incubated under hypoxic 
conditions showed homogeneously dense fibroblast 
and spindle-like appearance that meet the standard 
in-vitro characteristics of MSCs (Figure 1A). 
Osteogenic differentiation assay, the H-MSCs 
exhibited the calcium deposition under 2% Alizarin red 
staining that indicated the multipotency of H-MSCs 
was well-maintained as yet (Figure 1B). The flow 
cytometric analysis confirmed that H-MSCs expressed 
high levels of CD90, CD105 and CD73, and lack of 
Lin, according to the Internasional Society of Cellular 
Therapy (ISCT) as an immunophenotype 
characteristic of MSCs (Figure 1C). 
 
Figure 1 : A) H-MSC showed fibroblast and spindle-like shaped 
characteristic (scale bar 100 μm); B) Osteogenic differentiation of H-
MSCs was evidenced by calcium deposition as mineralized matrix 
that visualized by bright red color using Alizarin red staining (scale 
bar 50 μm) (magnification 10X); C) Immunophenotyping analysis of 
H-MSCs expressed CD90 (99.9%), CD105 (95.9%), CD73 (99.2%) 
and lacked the expression of Lin (2.0%) 
 
Macroscopic and microscopic analysis of 
 IPAs 
The results of macroscopic and microscopic 
analysis of IPAs are presented in Table 3.  
Table 3: Microscopic and macroscopic results of the groups 
and intergroup analysis 
 Group Macros appearance Micros appearance 
Sham 3.4 ± 0.89 3.4 ± 0.89 
Control 3.8 ± 0.44 4.0 ± 0.00 
T1 0.2 ± 0.44 0.0 ± 0.00 
T2 0.6 ± 0.89 0.2 ± 0.44 
Sham vs Control > 0.05 > 0.05 
Sham vs H-MSCs high dose < 0.05 < 0.05 
Sham vs H-MSCs low dose < 0.05 < 0.05 
Control vs H-MSCs high dose < 0.05 < 0.05 
Control vs H-MSCs low dose < 0.05 < 0.05 
H-MSCs High dose vs H-MSCs low dose < 0.05 < 0.05 
T1 = 3 x 10
6
 H-MSCs administration, T2 = 1.5 x 10
6
 H-MSCs administration. 
 
In our study, the macroscopic evaluation 
(Nair’s scale) showed significantly difference in the 
IPAs between treatment groups and control as well as 
sham (p < 0,05). We found the severe IPAs (grade 3-
4) at all control and sham groups (Figure 2), however, 
there was almost no adhesion in the T groups, 
particularly at T1 (high dose of H-MSC. 
 
Figure 2: Macroscopic appearance showed the severe peritoneal 
adhesions in A) the Sham group (3,4 ± 0,89) (red arrow) and B) 
Control group (3,8 ± 0,44) (red arrow); however, treatment groups 
showed there were almost no adhesions at C) the T1 group (0,2 ± 
0,44) (black arrow); and less peritoneal adhesions at D) the T2 
group (0,6 ± 0,89) (black arrow) 
 
In line with this finding, we also found there 
were significant difference of IPAs in the T group 
compare than control and sham at microscopic 
analysis (Zühlke’s scale) (p < 0.05) (Figure 3) that 
indicated HP-MSCs have a robust ability in preventing 
peritoneal adhesion. 
 
Figure 3: Microscopic appearance showed the severe peritoneal 
adhesion in A) the Sham and B) Control group respectively 3,4 ± 
0,89 and 4.0 ± 0,00 with thicker connective tissue (Black arrow) 
while in C) the T1 groups showed no peritoneal adhesion (0,0 ± 
0,00) and D) T2 groups was less peritoneal adhesion (0,2 ± 0,44) 
with weak connective tissue (black arrow) (magnification 10 X) 
 
IL-10 relative expression analysis 
The inflammatory status of all samples was 
assessed based on the existence of IL-10 expression 
as anti-inflammatory cytokines for controlling 
inflammation process. We found the significant 
difference in the IL-10 expression between T groups 
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and control as well as sham (p < 0,05) using RT-PCR 
analysis that indicated the upregulation of IL-10 at all 
dose of H-MSCs. The mean fold change was 
recorded and presented in the graph below (Figure 4). 
 
Figure 4: IL-10 expression in ileum tissue 
 
 
 
Discussion 
 
Adhesion formation following abdominal 
surgery may develop serious health problems ranging 
from severe pain up to bowel obstruction [1], [2], [3], 
[4], [5]. To decrease the IPAs event, MSCs 
administration has been performed either by topical or 
via systemic vein, however, the adhesion formation is 
occurred as yet [6], [7], [8]. The unique characteristic 
of mesothelial cells is considered as one of the failure 
factors of MSCs treatment due to the robust ability of 
this cell in modulating serosal inflammation than the 
other cells [17]. In terms of the serosa exposed to an 
injury or foreign agents, they may promote the 
development of chronic inflammation leading to 
peritoneal adhesion formation. Therefore, we 
performed the abrasion of the cecum followed by 
suturing a sterile absorbable thread to the omental 
patch as an animal model of IPAs. We used H-MSCs 
that have more potent in controlling the inflammation 
than N-MSCs. These are the first study demonstrated 
that H-MSCs have the ability in preventing the IPAs 
formation. 
In this study, we found that there was a 
significant difference in Nair’s macroscopic adhesion 
of IPAs (p < 0.05) between treatment and control 
groups. The grade 3-4 adhesion obviously occurs in 
all of the control group in the form of the viscera 
adhesion to the abdominal wall, whereas completely 
no adhesion in H-MSCs at high dose (T1). We also 
found a little bit of adhesions (grade 1) in H-MSCs 
treatment group at a low dose yet. Under 
physiological conditions, the remodelling phase leads 
to complete regeneration without permanent scars. 
However, in this study, the abrasion of the cecum 
along with the surgical suture thread as foreign 
antigen may promotes the pathogenic remodelling 
process leading to adhesion [18]. The damage of the 
peritoneal surface, particularly mesothelial cells 
following injury may induce the uncontrollably 
mesothelialized [19] and the prolonged inflammation 
[20], [21]. This is in line with our microscopy finding 
(Zühlke’s scale) in which we found many inflammation 
appearance in all control and sham groups. 
We found the fibrous bands of IPAs 
containing deposit collagen, and blood vessels in 
addition to inflammatory cells infiltration particularly 
lymphocytes in control and sham groups. However, 
we did not find them in the treatment group except 
leucocytes infiltration at the low dose of H-MSCs. 
These findings indicated that H-MSCs notably at high 
dose can optimally control inflammation [15]. 
Theoritically, the initial adhesion formation containing 
fibrin matrix occured under prolonged inflammation in 
which the synthesis of the ECM is more active than 
the degradation leading to the new endothelial layer 
formation connecting to other organs [22], [23]. These 
processes are caused by the continuous activated 
myofibroblast to produce an excessive amount of 
ECM due to the incompetence of IL-10 in suppressing 
the inflammation [13], [25]. Thus, to assess the 
controlled inflammation of treatment groups post H-
MSCs administration, IL-10 expression was 
evaluated. 
In this study, we found that there was a 
significant increase of IL-10 expression (p < 0,05) at 
all groups treatment. The lower IL-10 expression 
occured at the low dose (T2) of H-MSC than the high 
dose (T1) on day 14. This indicated that the low dose 
is not optimal in controlling the inflammation. This 
finding was in line with the microscopic appearance in 
which we found more inflammatory cells at low dose 
than high dose of H-MSCs. On the other side, we 
found a down-regulation of IL-10 expression on the 
control groups that are in accordance to the 
persistence infiltration of inflammatory cells. The 
inflammatory state may lead to the activation of 
myofibroblasts as the main effector cells of adhesion 
formations [1]. Binding of IL-10 post H-MSC 
administration to inflammatory cell receptor may 
activate tyrosine kinase-2 and Janus tyrosine kinase 1 
(JAK1) pathways, then translocate into the nucleus to 
induce the target genes such as the suppressor of 
cytokine signaling 3 (SOCS3) correlated with the 
decreased expression of TNF-  and IL-1  [27]. IL-10 
also has a gene target for effector downstream of 
MMP-9, iNOS, and IFN-  as well as MHC class II, 
thus they may inhibit the activation of inflammatory 
cells [29]. Specifically, IL-10 inhibit the release of 
TGF-β1 of activated macrophage, that have a key role 
to activate myofibroblasts. The myofibroblast 
inactivation may decrease the procollagen I and III 
production leading to the adhesion formation 
decrease [30]. This fact indicated that IL-10 has the 
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ability to inhibit both the innate and adaptive immune 
responses, in addition to inactivate the activated 
myofibroblast, thus may prevent IPAs formation. 
This study has several limitations in which we 
did not analyze TGF-β as the main molecule in 
activating myofibroblast as well as the alpha-smooth 
muscle actin (α-SMA) as the marker of the activated 
myofibroblast. Hence, we do not have clear 
observation of the role of IL-10 for myofibroblast 
activity. We also did not analyze the other 
inflammatory cytokines that may involve in adhesion 
formation. 
In conclusion, H-MSCs has a robust ability in 
inhibiting severe IPAs characterized by the decreased 
of adhesion on the terminal ileum tissues. The 
enhanced expression of IL-10 also indicates that there 
were acceleration of transition of the controlled 
inflammation to the completed healing process. This 
finding indicated that H-MSC may inhibit adhesion 
formation and inflamed tissue, thus may be 
considered as applicable agents for controlling IPAs in 
abdominal surgery. 
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